Silverarc Capital Management »

Kalvista Pharmaceuticals shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Kalvista Pharmaceuticals shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.7M 291k 16.15

More positions owned by Silverarc Capital Management

Abivax Sa Sponsored Ads (ABVX)
Cogent Biosciences (COGT)
Urogen Pharma (URGN)
Kalvista Pharmaceuticals (KALV)
Celcuity (CELC)
Nuvalent Inc-a (NUVL)
Dianthus Therapeutics (DNTH)
Kodiak Sciences (KOD)
Praxis Precision Medicines I Com New (PRAX)
Immunome (IMNM)
Fractyl Health (GUTS)
Uniqure Nv Call Call Option
Monte Rosa Therapeutics (GLUE)
Veracyte (VCYT)
Cg Oncology (CGON)

View all positions for Silverarc Capital Management

Top funds holding Kalvista Pharmaceuticals

Silverarc Capital Management
Group One Trading

View all funds holding Kalvista Pharmaceuticals